Katana VentraIP

Chinese Academy of Medical Sciences COVID-19 vaccine

Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences.

Vaccine description

SARS-CoV-2

Inactivated

Covidful (Chinese: 科维福; pinyin: Kēwéifú)

Intramuscular

  • Emergency authorization: China [1]

Clinical trials[edit]

In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.[2]


In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.[3]